Skip to Main Content

Paper Details

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
J Med Genet
147
2016
ATM, ATM c, ATM rare variants, BRCA2 mutations, CHEK2, CHEK2 c, CHEK2 c.1312G, CHEK2 c.1343T, G, G OR, PALB2, PALB2 c, breast cancer, c, c.1312G, c.1343T, c.538C, c.715G, c.7271T, cancer, iCOGS array, men, ovarian cancer, prostate cancer, rare variants, women
Author NameAffiliation
David E GoldgarHuntsman Cancer Institute
David E GoldgarHuntsman Cancer Institute
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
William D FoulkesLady Davis Institute, and Research Institute, McGill University Health Centre, McGill University
William D FoulkesLady Davis Institute, and Research Institute, McGill University Health Centre, McGill University
Jorge S Reis-FilhoMemorial Sloan-Kettering Cancer Center
Paolo RadiceFondazione IRCCS Istituto Nazionale dei Tumori (INT)
Christine L ClarkeUniversity of Sydney at the Westmead Institute for Medical Research
Christine L ClarkeUniversity of Sydney at the Westmead Institute for Medical Research
Rodney J ScottNewcastle and University of Newcastle
Peter A FaschingUniversity Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN
Peter A FaschingDavid Geffen School of Medicine, University of California at Los Angeles
Sune F NielsenHerlev Hospital, Copenhagen University Hospital, University of Copenhagen
Sune F NielsenHerlev Hospital, Copenhagen University Hospital, University of Copenhagen
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Javier Ben??tez
Hoda Anton-CulverUniversity of California Irvine
Hoda Anton-CulverUniversity of California Irvine
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Janet E OlsonMayo Clinic
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Brian E HendersonKeck School of Medicine, University of Southern California
Brian E HendersonKeck School of Medicine, University of Southern California
Fredrick R SchumacherKeck School of Medicine, University of Southern California
Fredrick R SchumacherKeck School of Medicine, University of Southern California
Loic Le MarchandCancer Research Center, University of Hawaii
Vessela N KristensenInstitute for Cancer Research, Oslo University Hospital, Radiumhospitalet
Vessela N KristensenUniversity of Oslo (UiO)
Wei ZhengVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
David J HunterHarvard School of Public Health
David J HunterHarvard School of Public Health
David J HunterHarvard School of Public Health
David J HunterHarvard School of Public Health
Susan E HankinsonHarvard School of Public Health
Susan E HankinsonBrigham and Women's Hospital and Harvard Medical School
Peter KraftHarvard School of Public Health
Peter KraftHarvard School of Public Health
Peter KraftHarvard School of Public Health
Peter KraftHarvard School of Public Health
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Julia A KnightLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Julia A KnightDalla Lana School of Public Health, University of Toronto
Caroline SeynaeveFamily Cancer Clinic, Erasmus MC-Daniel den Hoed Cancer Centre
  • 1 - 50

Datasets